Metabolic syndrome traits in long‐term survivors of pediatric sarcoma
Authors:
- Joanne DerdakJDJoanne Derdak
- Donna BernsteinDBDonna Bernstein
- Lynn GerberLGLynn Gerber
- Patrick J. ManskyPMPatrick J. Mansky
- 4 October 2007
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 50 (2) , 341-346
Abstract
Purpose: The metabolic syndrome (MS), a cluster of central obesity, dyslipidemia, hyperglycemia, and hypertension, conveys an increased risk of type 2 diabetes and cardiovascular disease. This cross‐sectional study investigated the prevalence of metabolic syndrome traits (MST) in long‐term survivors of pediatric sarcoma (SARC) who received multi‐modality therapy (MMT).Methods: Thirty‐two SARC survivors (predominantly Ewings; median age 36.5; median age at MMT 15) underwent body composition, activity, and psychosocial analysis. Serum endocrine and inflammatory parameters and urine beta(2)‐microglobulin (B2M) were evaluated. The prevalence of MST was compared to age‐ and gender‐matched U.S. population data.Results: SARC survivors were more likely to have two or more MST (OR 2.38 95% CI: [1.14, 5.04]). Analysis of individual MST demonstrated higher prevalence of hypertension (OR 2.61 95% CI: [1.20, 5.59]), hypertriglyceridemia (OR 3.63 95% CI: [1.75, 7.60]), and male visceral abdominal obesity (20–39 years old OR 4.63 95% CI: [0.91, 21.63], 40–59 years old OR infinity). Survivors 18–39 years old had a higher prevalence of the MS (OR 4.29 95% CI: [1.50, 11.21]), defined as three or more MST. Plasminogen activator inhibitory activity (P = 0.016) and B2M (P = 0.027) increased with increasing numbers of MST. In males, total testosterone declined (P = 0.0027) as the number of MST increased. Average (P = 0.014) and maximum (P = 0.021) activity levels decreased as the number of MST increased.Conclusion: After a median follow up of 17 years, adult SARC survivors of MMT had an increased prevalence of MST, especially those less than 40 years old. The development of MST in this population was associated with decreased testosterone and activity levels. Pediatr Blood Cancer 2008;50:341–346.Keywords
This publication has 36 references indexed in Scilit:
- Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemiaCancer, 2006
- Treatment late effects in long‐term survivors of pediatric sarcomaPediatric Blood & Cancer, 2006
- Persistent psychological distress in long-term survivors of pediatric sarcoma: the experience at a single institutionPsycho-Oncology, 2006
- The Metabolic Syndrome and Disturbances in Hormone Levels in Long-Term Survivors of Disseminated Testicular CancerJournal of Clinical Oncology, 2005
- Sedentary Behavior, Physical Activity, and the Metabolic Syndrome among U.S. AdultsObesity Research, 2005
- Endocrine and cardiovascular late effects among adult survivors of childhood brain tumorsCancer, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Do stress reactions cause abdominal obesity and comorbidities?Obesity Reviews, 2001
- Late Effects of Therapy in Survivors of Ewingʼs Sarcoma Family TumorsJournal of Pediatric Hematology/Oncology, 1997
- Functional cardiac disturbances related to chemotherapy independent of anthracycline use in children with neoplastic diseaseThe American Journal of Cardiology, 1995